Volume 20 No 9 (2022)
Download PDF
COMET ASSAY AS A RELIABLE BIOMARKER TO ASSESS THE DNA DAMAGE IN PATIENTS WITH PRECANCEROUS AND CANCEROUS ORAL LESIONS
Dr. Rashee Mittal, Dr. Amudalapalli S Narayana, Dr. Kiran T.V., Dr. Kiran Kumar p
Abstract
In India, tobacco is used in both smoked and smokeless forms, but chiefly it is used in the smokeless
form. Holding tobacco in the mouth allows the absorption of carcinogens present in it and also these
orally absorbed carcinogens stays in the blood for a longer duration of time. Habit of chewing tobacco
causes lesions in the oral cavity. These oral lesions can be precancerous or cancerous. If cancerous
condition is known in the beginning of the disease, there are chances to recover from that. To fulfill that
purpose we need some biomarkers that can predict the severity of the condition. One of the biomarker
we used and checked for its reliability in the present study and that is known as Comet assay. Comet
assay is a very versatile method, so can be used for any type of cells. The present study was undertaken
to know the effects of chewing tobacco on blood cells of patients with precancerous and cancerous oral
lesions. Comet assay was used as the biomarker for the assessment of the DNA damage. Results of the
present study clearly show that the DNA damage was more in cancerous patients than the precancerous
patients. The difference in DNA damage was highly significant (P<0.001) also. After the study we can
say that comet assay is a reliable biomarker to assess the DNA damage. This study can be proven as a
benchmark for future epidemiological studies in large populations
Keywords
Tobacco, Oral lesions, Comet assay
Copyright
Copyright © Neuroquantology
Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the Neuroquantology are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJECSE right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.